Reset filter
Keywords
Eligibility Determination ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

63 Search results.
Relevance Rating New first Old first

Eligibility Lung Cancer NCT01281787

- 5/26/18 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01281787

Eligibility Thoracic Neoplasms NCT01024413

- 11/6/18 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Erlotinib Versus Gefitinib in Advanced Non Small Cell Lung Cancer With exon21 Mutation：A Randomized Trial; ODM derived from: https://clinicaltrials.gov/show/NCT01024413

Eligibility Thoracic Neoplasms NCT00880971

- 11/6/18 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
To Evaluate Postoperative 3D Conform Radiotherapy in Patients With IIIA (N2) Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00880971

Eligibility Brain Cancer NCT01065805

- 8/20/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01065805

Eligibility Symptomatic Venous Thromboembolism NCT01567917

- 1/22/19 - 1 form, 2 itemgroups, 8 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Incidence of Venous Thromboembolism Following Surgery in Patients With Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01567917

Eligibility Advanced Cancers NCT01259284

- 5/29/16 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01259284

Eligibility Breast Cancer NCT02061527

- 2/6/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT02061527

Eligibility Breast Cancer NCT01736605

- 9/17/19 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effect of Meditation and Massage Therapy for Breast Cancer Patients Undergoing Tissue Reconstruction; ODM derived from: https://clinicaltrials.gov/show/NCT01736605

Eligibility Breast Cancer NCT01917578

- 9/20/21 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Three-dimensional Pathological and MRI Reconstruction; ODM derived from: https://clinicaltrials.gov/show/NCT01917578

Eligibility Tumors NCT01403779

- 1/23/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01403779

Eligibility Colorectal Cancer NCT00874406

- 1/2/18 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00874406

Eligibility Colorectal Cancer NCT00059930

- 8/3/16 - 1 form, 1 itemgroup, 16 items, 1 language
Itemgroup: Criteria
Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00059930

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial